Supernus Pharmaceuticals, Inc. (0LB2.L) Dividend Yield, History & Forecast

Supernus Pharmaceuticals, Inc. (0LB2.L) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the London Stock Exchange. The most recent ex-dividend date was March 15, 2022. market capitalization is approximately $2.87B.

Loading quote...

Frequently Asked Questions about Supernus Pharmaceuticals, Inc. (0LB2.L)

When does Supernus Pharmaceuticals, Inc. pay its next dividend?
The most recent ex-dividend date was March 15, 2022.
Is Supernus Pharmaceuticals, Inc. a Dividend Aristocrat?
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Supernus Pharmaceuticals, Inc. in?
Supernus Pharmaceuticals, Inc. (0LB2.L) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.